Medicine for treating apoptosis dysfunction containing oligosaccharides
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 15, 2004
Grant Date -
N/A
app pub date -
Dec 28, 2000
filing date -
Feb 3, 1998
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The invention concerns a medicine comprising, as active principle, an efficient quantity of at least an oligosaccharide substance capable of modulating apoptosis dysfunction which is capable of modifying apoptosis dysfunctions said substance being selected from the group consisting of oligosaccharides which are derived, by enzymatic or chemical process, from the polymers of the group comprising (1.fwdarw.3)-.beta.-glucans which optionally comprise (1.fwdarw.6)-.beta.-branching, and oligosaccharides which are derived, by enzymatic or chemical process, from sulfated galactans, it also concerns a method for treating apoptosis dysfunction.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully